INTENDED FOR UK AND IRELAND HEALTHCARE PROFESSIONALS Patient InformationHomePrescribing information

the CHIESI cf portfolio
LIVING & BREATHING CYSTIC FIBROSIS
Bramitob® (tobramycin) is for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.2

Find out more

1.Quinsair Summary of Product Characteristics, Chiesi Limited.
2.Bramitob Summary of Product Characteristics, Chiesi Limited.
3.Bronchitol Summary of Product Characteristics, Pharmaxis Europe Limited.

IE-CF-2000116  | Oct 2020